Terms: = Lung cancer AND BCL9L, BCL9-2, 283149, ENSG00000186174, DLNB11
5 results:
1. ΔNp63 regulates a common landscape of enhancer associated genes in non-small cell lung cancer.
Napoli M; Wu SJ; Gore BL; Abbas HA; Lee K; Checker R; Dhar S; Rajapakshe K; Tan AC; Lee MG; Coarfa C; Flores ER
Nat Commun; 2022 Feb; 13(1):614. PubMed ID: 35105868
[TBL] [Abstract] [Full Text] [Related]
2. The interactions of Bcl9/bcl9l with β-catenin and Pygopus promote breast cancer growth, invasion, and metastasis.
Vafaizadeh V; Buechel D; Rubinstein N; Kalathur RKR; Bazzani L; Saxena M; Valenta T; Hausmann G; Cantù C; Basler K; Christofori G
Oncogene; 2021 Oct; 40(43):6195-6209. PubMed ID: 34545187
[TBL] [Abstract] [Full Text] [Related]
3. Tumor-educated leukocytes mRNA as a diagnostic biomarker for non-small cell lung cancer.
Niu L; Guo W; Song X; Song X; Xie L
Thorac Cancer; 2021 Mar; 12(6):737-745. PubMed ID: 33474835
[TBL] [Abstract] [Full Text] [Related]
4. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
Katoh M
Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
[TBL] [Abstract] [Full Text] [Related]
5. Identification and characterization of human bcl9l gene and mouse bcl9l gene in silico.
Katoh M; Katoh M
Int J Mol Med; 2003 Oct; 12(4):643-9. PubMed ID: 12964048
[TBL] [Abstract] [Full Text] [Related]
